Taysha Gene Therapies News

Taysha Gene Therapies | DEFA14A: Others

Apr 19 04:27

Taysha Gene Therapies | ARS: Annual Report to Security Holders

Apr 19 04:23

Taysha Gene Therapies | DEF 14A: Definitive information statements

Apr 19 04:19

Taysha Gene Therapies | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

Mar 20 04:57

Taysha Gene Therapies | 8-K: Current report

Mar 20 04:22

Taysha Gene Therapies | 10-K: Annual report

Mar 20 04:18

Taysha Gene Therapies | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Venrock Healthcare Capital Partners III, L.P.(5.6%),VHCP Co-Investment Holdings III, LLC(5.6%), etc.

Feb 15 09:48

Taysha Gene Therapies | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-RA Capital Management, L.P.(9.99%),Peter Kolchinsky(9.99%), etc.

Feb 15 06:31

Taysha Gene Therapies | SC 13G: Statement of acquisition of beneficial ownership by individuals-RTW Investments, LP(9.8%),Roderick Wong, M.D.(9.8%)

Feb 14 20:11

Taysha Gene Therapies | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-TCG Crossover GP I, LLC(1.6%),TCG Crossover Fund I, L.P.(1.6%), etc.

Feb 10 05:31

Taysha Gene Therapies | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-FMR LLC(12.002%),Abigail P. Johnson(12.002%)

Feb 9 22:56

Taysha Gene Therapies | 4: Statement of changes in beneficial ownership of securities-Officer Alam Kamran

Feb 7 05:43

Taysha Gene Therapies | 8-K: Current report

Jan 10 13:00

Taysha Gene Therapies | 4: Statement of changes in beneficial ownership of securities-Officer Alam Kamran

Jan 4 13:00

Taysha Gene Therapies | 4: Statement of changes in beneficial ownership of securities-Officer Nagendran Sukumar

Jan 4 13:00

Taysha Gene Therapies | 4: Statement of changes in beneficial ownership of securities-Officer Nolan Sean P.

Jan 4 13:00

Taysha Gene Therapies | 8-K: Current report

Dec 21, 2023 05:21

Taysha Gene Therapies | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

Dec 21, 2023 05:20

Taysha Gene Therapies | 4: Statement of changes in beneficial ownership of securities-Chief Financial Officer Alam Kamran

Dec 19, 2023 05:50

Taysha Gene Therapies | 4: Statement of changes in beneficial ownership of securities-Officer Nagendran Sukumar

Dec 19, 2023 05:47